Pfizer reported for 9 months of 2023

Pfizer's GAAP net income for 9 months of 2023 amounted to $5.518 billion, down 4.8 times from $26.404 billion in the previous year. Revenue declined 41.8% to $44.247 billion from $76.04 billion a year earlier.